Anemia; Hemodialysis Dependent Chronic Kidney Disease Clinical Trial
Official title:
A Phase III, Open-label Study of MT-6548 in Hemodialysis Subjects With Anemia Associated With Chronic Kidney Disease in Japan
For hemodialysis subjects not receiving ESAs with anemia associated with chronic kidney disease, evaluate Hb correction and maintenance effect and safety of MT-6548.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03439137 -
Efficacy and Safety Study to Evaluate MT-6548 in Hemodialysis Subjects Currently Receiving ESAs With Anemia Associated With Chronic Kidney Disease in Japan
|
Phase 3 |